Skip to content
Catalyst

PapersPMID:39940348

Mango Consumption Is Associated with Increased Insulin Sensitivity in Participants with Overweight/Obesity and Chronic Low-Grade Inflammation.

Nutrients2025The record ↗

findings
2
compound
1
endpoints
2
no difference found
1
  1. Finding, moderate evidencelowersHOMA-IR
  2. Finding, moderate evidenceno difference foundFasting blood glucose
Study, every finding
RCT · 4 weeks
Dose studied, every finding
2 servings/day (one morning, one afternoon), each 126.9 g Kent mango plus 38.1 g Keitt mango
Population, every finding
Adults with overweight or obesity (BMI 25 or more), chronic low-grade inflammation and fasting glucose 100 to 125 mg/dL, aged 20 to 60; randomized single-blinded parallel trial; control an energy-matched (100 kcal) Italian-ice-based product
  • “Additionally, HOMA-IR was significantly lower after the mango intervention than the control intervention (2.28 ± 1.19 vs. 4.67 ± 1.21, p = 0.03), as were the delta differences between interventions (p = 0.0009).”

What did not

  • “At the end of week 4, fasting glucose concentrations were not significantly different between mango and control interventions (119.67 ± 1.02 mg/dL vs. 116.95 ± 1.02 mg/dL, p = 0.51).”

Study record

Design
randomised controlled trial
Species
human
Population
Adults with overweight or obesity (BMI of 25 kg/m2 or more) and chronic low-grade inflammation, Chicago; fresh frozen whole mango (Kent and Keitt varieties), not an extract
Participants
48
Comparator
placebo
Duration
28 days
Endpoints measured
17